Elsevier

Appetite

Volume 7, Supplement, 1986, Pages 15-38
Appetite

Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system

https://doi.org/10.1016/S0195-6663(86)80050-2Get rights and content

The neurochemical mechanisms by which drugs acting on central serotoninergic system modify feeding were reviewed. Fenfluramine, a clinically effective appetite suppressant, releases serotonin from nerve terminals and inhibits its reuptake, and considerable evidence suggests that these effects mediate its anorectic activity. The d isomer of fenfluramine is particularly specific in affecting serotonin mechanisms and causing anorexia. Transmitters other than serotonin such as acetylcholine, catecholamines and GABA are also affected by systemic administration of fenfluramine, but some of these effects are secondary to fenfluramine's action on serotoninergic mechanisms. Moreover, there is no evidence that these brain substances are involved in fenfluramine's ability to cause anorexia.

Several studies with drugs affecting different serotonin mechanisms such as release and uptake or mimicking the action of serotonin at post-synaptic receptors suggest that increase serotonin release and direct stimulation of postsynaptic receptors are the most effective mechanisms for causing depression of food intake, although inhibition of serotonin uptake may also contribute in appropriate conditions.

Development of serotonin receptor hyposensitivity and, in some instances, decreased serotonin levels may lead to tolerance to the anorectic activity of drugs enhancing serotonin transmission, the degree of this depending critically on the type of effect on serotonin mechanisms and intensity and duration of serotonin receptor activation.

Recent evidence suggests that a decrease in serotonin function causes stimulation of feeding. This may lead to development of new strategies for the treatment of clinical anorexias.

References (102)

  • D. Ghezzi et al.

    Effect of thymoleptics on fenfluramine-induced depletion of brain serotonin in rats

    European Journal of Pharmacology

    (1973)
  • L. Grandison et al.

    Stimulation of food intake by muscimol and beta endorphin

    Neuropharmacology

    (1977)
  • L.G. Harsing et al.

    Elevation of met5-enkephalin and β-endorphin hypothalamic content in rats receiving anorectic drugs: Differences between D- fenfluramine and D-amphetamine

    Neuropharmacology

    (1982)
  • R.L. Hauger et al.

    Characteristics of [3H]-( + )- amphetamine binding sites in the rat central nervous system

    Life Sciences

    (1984)
  • R. Invernizzi et al.

    Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats

    Neurochemistry International

    (1981)
  • J. Kelly et al.

    GABA and hypothalamic feeding systems. I. Topographic analysis of the effects of microinjections of muscimol

    Physiology & Behavior

    (1979)
  • Y. Kohno et al.

    Simultaneous determination of noradrenaline and 3-methoxy-4-hydroxy-phenylethyleneglycol sulfate in discrete brain regions of the rat

    Analytical Biochemistry

    (1979)
  • D.A. Levitsky et al.

    Tolerance to anorectic drugs: Pharmacological or artifactual

    Pharmacology, Biochemistry & Behavior

    (1981)
  • N.Y. Liang et al.

    Evidence for carrier-mediated efflux of dopamine from corpus striatum

    Biochemical Pharmacology

    (1982)
  • N.Y. Liang et al.

    Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine

    Biochemical Pharmacology

    (1982)
  • G. Maura et al.

    Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings

    Neurochemistry International

    (1982)
  • T. Mennini et al.

    Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin

    Neurochemistry International

    (1981)
  • D. Morgan et al.

    Amphetamine analogues and brain amines

    Life Sciences

    (1972)
  • N. Rowland et al.

    Differences among ‘serotonergic’ anorectics in a cross-tolerance paradigm: Do they all act on serotonin systems?

    European Journal of Pharmacology

    (1982)
  • R. Samanin et al.

    The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine

    European Journal of Pharmacology

    (1972)
  • R. Samanin et al.

    Evidence that it is possible to cause anorexia by increasing release and/or directly stimulating postsynaptic serotonin receptors in the brain

    Progress in Neuro-Psychopharmacology

    (1980)
  • R. Samanin et al.

    Hyper- and hyposensitivity of central serotonin receptors: [3H] serotonin binding and functional studies in the rat

    Brain Research

    (1980)
  • J.C. Schwartz et al.

    Modulation of receptor mechanisms in the CNS: Hyper- and hyposensitivity to catecholamines

    Neuropharmacology

    (1978)
  • L.R. Steranka et al.

    Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons

    Biochemical Pharmacology

    (1979)
  • E.S. Vizi et al.

    Evidence of the modulatory role of serotonin in acetylcholine release from striatal intraneurons

    Brain Research

    (1981)
  • G. Achilli et al.

    Simultaneous determination of DA, NA, 5HT and their metabolites in several rat brain areas by HPLC with electrochemical detection

    Research Communications in Chemical Pathology and Pharmacology

    (1983)
  • S. Ahlenius et al.

    Lisuride, LY-141865, and 8-OH-DPAT facilitate male rat sexual behavior via a non-dopaminergic. mechanism

    Psychopharmacology

    (1984)
  • J.E. Ahlskog et al.

    Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain. 6-hydroxydopamine

    Psychopharmacology

    (1984)
  • S.M. Antelman et al.

    Anorectics: Lack of cross tolerance among serotonergic drugs and sensitization of amphetamine's effect

  • J.D. Belluzzi et al.

    Do enkephalin systems mediated drive reduction?

    Society for Neuroscience Abstracts

    (1978)
  • A. Bianchetti et al.

    Pharmacological characterization of CM 57227, a new anorexigenic agent

  • J.E. Blundell et al.

    Pharmacological manipulation of feeding behavior: Possible influences of serotonin and dopamine on food intake

  • F. Borsini et al.

    The roles of brain noradrenaline and dopamine in the anorectic activity of diethylproprion in rats. A comparison with. D-amphetamine

    Research Communications in Chemical Pathology and Pharmacology

    (1979)
  • S. Bourgoin et al.

    Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor. blocker

    Naunyn-Schmiedeberg's Archives of Pharmacology

    (1978)
  • D.R. Burt et al.

    Properties of [3H] haloperidol and [3H] dopamine binding associated with dopamine receptors in calf brain. membranes

    Molecular Pharmacology

    (1976)
  • B.V. Clineschmidt et al.

    Fenfluramine and brain. serotonin

    Annals of the New York Academy of Sciences

    (1978)
  • S. Consolo et al.

    Differential effects of the isomers of fenfluramine and norfenfluramine on rat striatal acetylcholine content

    Journal of Pharmacy and Pharmacology

    (1979)
  • S. Consolo et al.

    Comparison of the effects of the stereoisomers of fenfluramine on the acetylcholine content of rat striatum, hippocampus and nucleus. accumbens

    Journal of Pharmacy and Pharmacology

    (1980)
  • E. Costa et al.

    Action of fenfluramine on monoamine stores of rat tissues

    British Journal of Pharmacology

    (1971)
  • B. Costall et al.

    The role of the raphé and extrapyramidal nuclei in the stereotyped and circling responses to quipazine

    Journal of Pharmacy and Pharmacology

    (1975)
  • G. Curzon et al.

    The serotonin agonist 8-OH-DPAT elicits feeding in non-deprived rats

    British Journal of Pharmacology

    (1984)
  • W.W. Douglas et al.
  • J. Duhault et al.

    Modification du taux de Serotonine cérébrale chez le rat par les trifluorométhylphenyl-2-éthyl aminopropane (fenfluramine 768 S)

    Archives Internationales de Pharmacodynamic et de Therapie

    (1967)
  • R.W. Fuller et al.

    Decreased accumulation of brain 5-hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p- chloroamphetamine

    Journal of Pharmacy and Pharmacology

    (1983)
  • W.H. Funderburk

    Lack of cytotoxic effect of fenfluramine

    Neurochemical Research

    (1977)
  • Cited by (187)

    • Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know

      2021, Pharmacology and Therapeutics
      Citation Excerpt :

      In the same experimental system, d-fenfluramine and d-norfenfluramine also released noradrenaline, whereas l-fenfluramine did not affect noradrenaline release and l-norfenfluramine was weakly active (Rothman, Clark, Partilla, & Beumann, 2003). The release of 5-HT induced by d-fenfluramine is preferentially exocytotic while norfenfluramine mainly acts on the non-vesicular pool (Garattini et al., 1986). Although both fenfluramine enantiomers and their metabolites have no major effects on dopaminergic mechanisms in vitro, l-fenfluramine and l-norfenfluramine have several biochemical and behavioral effects typical of antipsychotic drugs in experimental models, suggesting that they may control dopamine transmission in vivo (Bendotti, Borsini, Zanini, Samanin, & Garattini, 1980; Bettini, Ceci, Spinelli, & Samanin, 1987; Garattini et al., 1986; Invernizzi, Berettera, Garattini, & Samanin, 1986; Invernizzi, Bertorelli, Consolo, Garattini, & Samanin, 1989; Rothman et al., 2003).

    • Role of the serotonergic system in appetite and ingestion control

      2020, Handbook of Behavioral Neuroscience
      Citation Excerpt :

      Blundell's seminal review (Blundell, 1977), which became a citation classic, synthesized these early studies and proposed that endogenous serotonin inhibits food consumption by augmenting short-term satiety processes during both a meal and the subsequent postingestive period. Much of our understanding of the role of the serotonergic system in the control of appetite and ingestive behavior has developed from studies carried out between the 1970s and early 1990s using the serotonin releaser and reuptake inhibitor fenfluramine (Garattini et al., 1986, 1987), initially with the racemic dl-fenfluramine and later the more potent isomer d-fenfluramine. In fact, until 1997 when fenfluramine was withdrawn as an antiobesity treatment due to its association with valvular heart disease (Connolly et al., 1997), it was the prototypical compound for investigating serotonergic mechanisms underpinning food intake and satiety.

    • New therapeutic opportunities for 5-HT<inf>2</inf> receptor ligands

      2017, Pharmacology and Therapeutics
      Citation Excerpt :

      However, clinical use of DF has been associated with several unacceptable side effects including primary pulmonary hypertension and valvular heart disease (Fitzgerald et al., 2000; Rothman et al., 2000; Launay et al., 2002), and this anorexigen was withdrawn from the market in 1997. In the early 1980s, Mennini and colleagues performed pioneering work initially describing the effect of DF and derivatives on the release of 5-HT into nerve terminals by targeting the serotonin transporter (SERT) (Garattini et al., 1986). Administration of DF suppresses food intake in both animals and humans.

    • Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention

      2015, Asian Journal of Psychiatry
      Citation Excerpt :

      Human studies confined the suppression of intake of highly palatable high fat foods and a possible avoidance of fat after the administration of dexfenfluramine and sumatriptan (Blundell and Halford, 1998). The role of serotonin in the regulation of the food intake has been explored in several earlier studies (Blundell et al., 1984; Garattini et al., 1986). Serotonin release or uptake inhibitor, fenfluramine is reported to inhibit food intake in both animals (Duhault et al., 1975) and humans (Silverstone and Goodall, 1986).

    • Serotonin controlling feeding and satiety

      2015, Behavioural Brain Research
    View all citing articles on Scopus
    View full text